FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Scopolamine (Transderm Scop) Transdermal System Patch
Status: Currently in Shortage
»Date first posted: 09/15/2016
»Therapeutic Categories: Endocrinology/Metabolism; Neurology

Expand all

Sandoz (Reverified 04/19/2017)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Transderm (Scopolamine) 1.5 mg Patch 10 count (NDC 10019-553-01) Product replaced by 10019-553-03. The availability of this presentation is listed with a status of having possible intermittent backorders. Please call Baxter Healthcare Corporation at 1-888-229-0001 Demand increase for the drug
Transderm (Scopolamine) 1.5 mg Patch 24 count (NDC 10019-553-02) Product replaced by 10019-553-04, which is available. Please call Baxter Healthcare Corporation at 1-888-229-0001 Requirements related to complying with good manufacturing practices
Transderm (Scopolamine) 1.5 mg Patch 4 count (NDC 0067-4345-04) Product replaced by 66758-208-54. Supply available now. Intermittent backorders possible. Requirements related to complying with good manufacturing practices

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English